Increase/Decrease in Cash: The total change in cash for the company over the given period.
Telix Pharmaceuticals Limited (TLX) had Increase/Decrease in Cash of $-232.84M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$398.01M |
|
$42.46M |
|
$791.94M |
|
$1.19B |
|
$298.58M |
|
$397.19M |
|
$469.43M |
|
$768.01M |
|
$421.94M |
|
$-162.23M |
|
$421.94M |
|
338.40M |
|
| Cash Flow Statement Financials | |
$17.75M |
|
$-258.85M |
|
$-2.92M |
|
$440.00M |
|
$207.16M |
|
|
Increase/Decrease in Cash |
$-232.84M |
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|